Global Multiple Sclerosis Therapeutics Supply, Demand and Key Producers, 2023-2029

Page: 101

Published Date: 11 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

This report studies the global Multiple Sclerosis Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Multiple Sclerosis Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multiple Sclerosis Therapeutics that contribute to its increasing demand across many markets.

The global Multiple Sclerosis Therapeutics market size is expected to reach $ 20010 million by 2029, rising at a market growth of 1.9% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Multiple Sclerosis Therapeutics total market, 2018-2029, (USD Million)
Global Multiple Sclerosis Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Multiple Sclerosis Therapeutics total market, key domestic companies and share, (USD Million)
Global Multiple Sclerosis Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Multiple Sclerosis Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Multiple Sclerosis Therapeutics total market by Distribution Channel, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Multiple Sclerosis Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Teva Pharmaceuticals, Sanofi Genzyme, Bayer, Pfizer, Biogen Idec, Merck and AbbVie, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multiple Sclerosis Therapeutics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Distribution Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Multiple Sclerosis Therapeutics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Multiple Sclerosis Therapeutics Market, Segmentation by Type
    Beta Interferon
    Corticosteroids
    Monoclonal Antibodies
    Antineoplastic Agents
    Others

Global Multiple Sclerosis Therapeutics Market, Segmentation by Distribution Channel
    Hospital Pharmacies
    Retail Pharmacies
    e-Commerce

Companies Profiled:
    Novartis
    Teva Pharmaceuticals
    Sanofi Genzyme
    Bayer
    Pfizer
    Biogen Idec
    Merck
    AbbVie

Key Questions Answered
1. How big is the global Multiple Sclerosis Therapeutics market?
2. What is the demand of the global Multiple Sclerosis Therapeutics market?
3. What is the year over year growth of the global Multiple Sclerosis Therapeutics market?
4. What is the total value of the global Multiple Sclerosis Therapeutics market?
5. Who are the major players in the global Multiple Sclerosis Therapeutics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Multiple Sclerosis Therapeutics Introduction
    1.2 World Multiple Sclerosis Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Multiple Sclerosis Therapeutics Total Market by Region (by Headquarter Location)
        1.3.1 World Multiple Sclerosis Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.3 China Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.4 Europe Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.5 Japan Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.6 South Korea Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.7 ASEAN Multiple Sclerosis Therapeutics Market Size (2018-2029)
        1.3.8 India Multiple Sclerosis Therapeutics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Multiple Sclerosis Therapeutics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Multiple Sclerosis Therapeutics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.2 World Multiple Sclerosis Therapeutics Consumption Value by Region
        2.2.1 World Multiple Sclerosis Therapeutics Consumption Value by Region (2018-2023)
        2.2.2 World Multiple Sclerosis Therapeutics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.4 China Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.5 Europe Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.6 Japan Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.7 South Korea Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.8 ASEAN Multiple Sclerosis Therapeutics Consumption Value (2018-2029)
    2.9 India Multiple Sclerosis Therapeutics Consumption Value (2018-2029)

3 World Multiple Sclerosis Therapeutics Companies Competitive Analysis
    3.1 World Multiple Sclerosis Therapeutics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Multiple Sclerosis Therapeutics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Multiple Sclerosis Therapeutics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Multiple Sclerosis Therapeutics in 2022
    3.3 Multiple Sclerosis Therapeutics Company Evaluation Quadrant
    3.4 Multiple Sclerosis Therapeutics Market: Overall Company Footprint Analysis
        3.4.1 Multiple Sclerosis Therapeutics Market: Region Footprint
        3.4.2 Multiple Sclerosis Therapeutics Market: Company Product Type Footprint
        3.4.3 Multiple Sclerosis Therapeutics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Multiple Sclerosis Therapeutics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Multiple Sclerosis Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Multiple Sclerosis Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Multiple Sclerosis Therapeutics Consumption Value Comparison
        4.2.1 United States VS China: Multiple Sclerosis Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Multiple Sclerosis Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Multiple Sclerosis Therapeutics Companies and Market Share, 2018-2023
        4.3.1 United States Based Multiple Sclerosis Therapeutics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023)
    4.4 China Based Companies Multiple Sclerosis Therapeutics Revenue and Market Share, 2018-2023
        4.4.1 China Based Multiple Sclerosis Therapeutics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023)
    4.5 Rest of World Based Multiple Sclerosis Therapeutics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Multiple Sclerosis Therapeutics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Multiple Sclerosis Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Beta Interferon
        5.2.2 Corticosteroids
        5.2.3 Monoclonal Antibodies
        5.2.4 Antineoplastic Agents
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Multiple Sclerosis Therapeutics Market Size by Type (2018-2023)
        5.3.2 World Multiple Sclerosis Therapeutics Market Size by Type (2024-2029)
        5.3.3 World Multiple Sclerosis Therapeutics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Distribution Channel
    6.1 World Multiple Sclerosis Therapeutics Market Size Overview by Distribution Channel: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Distribution Channel
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 e-Commerce
    6.3 Market Segment by Distribution Channel
        6.3.1 World Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2018-2023)
        6.3.2 World Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2024-2029)
        6.3.3 World Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2018-2029)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Multiple Sclerosis Therapeutics Product and Services
        7.1.4 Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Teva Pharmaceuticals
        7.2.1 Teva Pharmaceuticals Details
        7.2.2 Teva Pharmaceuticals Major Business
        7.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product and Services
        7.2.4 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Teva Pharmaceuticals Recent Developments/Updates
        7.2.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Sanofi Genzyme
        7.3.1 Sanofi Genzyme Details
        7.3.2 Sanofi Genzyme Major Business
        7.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Product and Services
        7.3.4 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Sanofi Genzyme Recent Developments/Updates
        7.3.6 Sanofi Genzyme Competitive Strengths & Weaknesses
    7.4 Bayer
        7.4.1 Bayer Details
        7.4.2 Bayer Major Business
        7.4.3 Bayer Multiple Sclerosis Therapeutics Product and Services
        7.4.4 Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bayer Recent Developments/Updates
        7.4.6 Bayer Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Multiple Sclerosis Therapeutics Product and Services
        7.5.4 Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Biogen Idec
        7.6.1 Biogen Idec Details
        7.6.2 Biogen Idec Major Business
        7.6.3 Biogen Idec Multiple Sclerosis Therapeutics Product and Services
        7.6.4 Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Biogen Idec Recent Developments/Updates
        7.6.6 Biogen Idec Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Multiple Sclerosis Therapeutics Product and Services
        7.7.4 Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 AbbVie
        7.8.1 AbbVie Details
        7.8.2 AbbVie Major Business
        7.8.3 AbbVie Multiple Sclerosis Therapeutics Product and Services
        7.8.4 AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 AbbVie Recent Developments/Updates
        7.8.6 AbbVie Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Multiple Sclerosis Therapeutics Industry Chain
    8.2 Multiple Sclerosis Therapeutics Upstream Analysis
    8.3 Multiple Sclerosis Therapeutics Midstream Analysis
    8.4 Multiple Sclerosis Therapeutics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Multiple Sclerosis Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Multiple Sclerosis Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Multiple Sclerosis Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Multiple Sclerosis Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Multiple Sclerosis Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Multiple Sclerosis Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Multiple Sclerosis Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Multiple Sclerosis Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Multiple Sclerosis Therapeutics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Multiple Sclerosis Therapeutics Players in 2022
    Table 12. World Multiple Sclerosis Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Multiple Sclerosis Therapeutics Company Evaluation Quadrant
    Table 14. Head Office of Key Multiple Sclerosis Therapeutics Player
    Table 15. Multiple Sclerosis Therapeutics Market: Company Product Type Footprint
    Table 16. Multiple Sclerosis Therapeutics Market: Company Product Application Footprint
    Table 17. Multiple Sclerosis Therapeutics Mergers & Acquisitions Activity
    Table 18. United States VS China Multiple Sclerosis Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Multiple Sclerosis Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Multiple Sclerosis Therapeutics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Multiple Sclerosis Therapeutics Revenue Market Share (2018-2023)
    Table 23. China Based Multiple Sclerosis Therapeutics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Multiple Sclerosis Therapeutics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Multiple Sclerosis Therapeutics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Multiple Sclerosis Therapeutics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Multiple Sclerosis Therapeutics Revenue Market Share (2018-2023)
    Table 29. World Multiple Sclerosis Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Multiple Sclerosis Therapeutics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Multiple Sclerosis Therapeutics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Multiple Sclerosis Therapeutics Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
    Table 33. World Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2018-2023) & (USD Million)
    Table 34. World Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2024-2029) & (USD Million)
    Table 35. Novartis Basic Information, Area Served and Competitors
    Table 36. Novartis Major Business
    Table 37. Novartis Multiple Sclerosis Therapeutics Product and Services
    Table 38. Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis Recent Developments/Updates
    Table 40. Novartis Competitive Strengths & Weaknesses
    Table 41. Teva Pharmaceuticals Basic Information, Area Served and Competitors
    Table 42. Teva Pharmaceuticals Major Business
    Table 43. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product and Services
    Table 44. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Teva Pharmaceuticals Recent Developments/Updates
    Table 46. Teva Pharmaceuticals Competitive Strengths & Weaknesses
    Table 47. Sanofi Genzyme Basic Information, Area Served and Competitors
    Table 48. Sanofi Genzyme Major Business
    Table 49. Sanofi Genzyme Multiple Sclerosis Therapeutics Product and Services
    Table 50. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Sanofi Genzyme Recent Developments/Updates
    Table 52. Sanofi Genzyme Competitive Strengths & Weaknesses
    Table 53. Bayer Basic Information, Area Served and Competitors
    Table 54. Bayer Major Business
    Table 55. Bayer Multiple Sclerosis Therapeutics Product and Services
    Table 56. Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Bayer Recent Developments/Updates
    Table 58. Bayer Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer Multiple Sclerosis Therapeutics Product and Services
    Table 62. Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Biogen Idec Basic Information, Area Served and Competitors
    Table 66. Biogen Idec Major Business
    Table 67. Biogen Idec Multiple Sclerosis Therapeutics Product and Services
    Table 68. Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Biogen Idec Recent Developments/Updates
    Table 70. Biogen Idec Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Multiple Sclerosis Therapeutics Product and Services
    Table 74. Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. AbbVie Basic Information, Area Served and Competitors
    Table 77. AbbVie Major Business
    Table 78. AbbVie Multiple Sclerosis Therapeutics Product and Services
    Table 79. AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 80. Global Key Players of Multiple Sclerosis Therapeutics Upstream (Raw Materials)
    Table 81. Multiple Sclerosis Therapeutics Typical Customers
List of Figure
    Figure 1. Multiple Sclerosis Therapeutics Picture
    Figure 2. World Multiple Sclerosis Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Multiple Sclerosis Therapeutics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Multiple Sclerosis Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Multiple Sclerosis Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Multiple Sclerosis Therapeutics Revenue (2018-2029) & (USD Million)
    Figure 13. Multiple Sclerosis Therapeutics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Multiple Sclerosis Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Multiple Sclerosis Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Multiple Sclerosis Therapeutics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Multiple Sclerosis Therapeutics Markets in 2022
    Figure 27. United States VS China: Multiple Sclerosis Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Multiple Sclerosis Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Multiple Sclerosis Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2022
    Figure 31. Beta Interferon
    Figure 32. Corticosteroids
    Figure 33. Monoclonal Antibodies
    Figure 34. Antineoplastic Agents
    Figure 35. Others
    Figure 36. World Multiple Sclerosis Therapeutics Market Size Market Share by Type (2018-2029)
    Figure 37. World Multiple Sclerosis Therapeutics Market Size by Distribution Channel, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2022
    Figure 39. Hospital Pharmacies
    Figure 40. Retail Pharmacies
    Figure 41. e-Commerce
    Figure 42. Multiple Sclerosis Therapeutics Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Multiple Sclerosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Multiple Sclerosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 02 Jul 2021

date Pharma & Healthcare

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Multiple Sclerosis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Multiple Sclerosis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

Global Multiple Sclerosis Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Multiple Sclerosis Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Pharma & Healthcare

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

Global Multiple Sclerosis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Multiple Sclerosis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Multiple Sclerosis Therapeutics market size was valued at USD 17530 million in 2023 and is forecast to a readjusted size of USD 20010 million by 2030 with a CAGR of 1.9% during review period.

Product Tags

multiple sclerosis therapeutics

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>